logo
ProjectCompleted

Jubilant Pharma

Sector: Water Supply and Storage • Location: India

Source: International Finance Corporation (IFC)

JPL’s manufacturing facilities in India include 2 facilities, i.e. (a) Nanjangud manufacturing APIs and (b) Roorkee manufacturing generics (tablets and capsules). In addition, the North American facilities, i.e. 2 facilities in United States of America (in Salisbury, Maryland and Spokane, Washington) and 1 in Canada (Kirkland, Quebec) are part of the pharmaceuticals business. The North American fa

Status
Closed
Sector
Water Supply and Storage, Oil and Gas, Chemical (Industrial), Manufacturing (Industrial), Aerospace & Defense, Warehouse, Waste Processing and Treatment, Government, Hospital, Commercial
Location
India
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Jubilant Pharma

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Jubilant Pharma” is an infrastructure initiative in the Water Supply and Storage sector, located in India. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

JPL’s manufacturing facilities in India include 2 facilities, i.e. (a) Nanjangud manufacturing APIs and (b) Roorkee manufacturing generics (tablets and capsules). In addition, the North American facilities, i.e. 2 facilities in United States of America (in Salisbury, Maryland and Spokane, Washington) and 1 in Canada (Kirkland, Quebec) are part of the pharmaceuticals business. The North American facilities manufacture ointments, creams and liquids (OCLs), sterile injectable, allergy therapy, generics (tablets and capsules), and radiopharmaceuticals.As indicated above, JPL is a fully owned subsidiary of JLS, which is a part of an Indian conglomerate Jubilant Bhartia Group (“JBG” or “the Group”). Headquartered in Noida (Uttar Pradesh) near Delhi, the Group has presence in diverse sectors, in addition to Pharmaceuticals and Life Science Ingredients (LSI), which include Food (Jubilant Food works), Agri & Performance Polymers (Jubilant Industries Limited), Oil & Gas (Jubilant Energy), Retail (Jubilant Retail), Auto (Jubilant Motor works), and Consulting Services in Aerospace & Oilfield industries (Jubilant Enpro).The proposed investment involves an overall IFC arranged financing package (“the Project”) in a combination of quasi equity and debt (including mobilization) to allow JLS to finance the transfer of its Indian pharmaceutical operating assets to JPL and thus consolidate its overall pharmaceutical business under JPL. In the process, the proposed transfer of the Indian assets to Jubilant Generics Ltd (JGL), incorporated in India as a subsidiary of JPL, will enable JLS to decouple fully its chemicals and pharmaceutical businesses for the primary purpose of creating more shareholder value through an offshore listing of JPL once the consolidation is in place. There will not be physical relocation of the production facilities.

Original sector

G-FA - Pharmaceuticals and Medicine

Location

Country

India

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Water Supply and Storage, Oil and Gas, Chemical (Industrial), Manufacturing (Industrial), Aerospace & Defense, Warehouse, Waste Processing and Treatment, Government, Hospital, Commercial

Article published date

2025-09-10

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project